Skip to content

Anti-MDA5 Antibody (Serum) – Quantitative Immunoassay

Published: August 9, 2026Updated: August 16, 2026

This test measures the presence of antibodies against the MDA5 protein, which may be linked to certain inflammatory or autoimmune conditions of the lungs and skin.

Quick summary

["This test helps diagnose rare lung diseases like idiopathic pulmonary fibrosis (IPF) or anti-melanoma differentiation-associated protein 5 (MDA5)-related interstitial lung disease."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
105529-2
Short code
MDA5 Ab Ser-aCnc
Synonyms
MDA5 Ab Ser-aCnc
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

What This Test Measures

The MDA5 protein is involved in immune responses, and antibodies against it can indicate an autoimmune reaction. This test detects these antibodies in your blood using an immunoassay method, which identifies specific proteins that your immune system has produced against MDA5.

Why It Might Be Ordered

Your healthcare provider may order this test if you have symptoms like persistent cough, shortness of breath, or skin rashes that don’t improve with standard treatments. It’s particularly useful for diagnosing conditions like anti-MDA5-associated interstitial lung disease, which can affect both lung function and skin health.

Common Symptoms Linked to Positive Results

Positive results may be associated with symptoms such as dry cough, progressive shortness of breath, or skin changes like rash, redness, or ulcers. These symptoms can vary widely and may overlap with other lung or autoimmune diseases.

What to Expect During Testing

A blood sample will be drawn from a vein in your arm. The sample is then processed and tested for the presence of anti-MDA5 antibodies. Results are typically available within 3–5 business days, depending on lab processing times.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

Anti-MDA5 Antibody

Frequently asked questions

What does a positive result mean?
A positive result suggests the presence of anti-MDA5 antibodies, which can indicate an autoimmune condition affecting the lungs and skin. This is not a definitive diagnosis but may prompt further testing or evaluation by a specialist, such as a pulmonologist or rheumatologist, to guide treatment options.
What does a negative result mean?
A negative result means no detectable anti-MDA5 antibodies were found in your sample. However, this does not rule out other possible causes of your symptoms. Your healthcare provider may recommend additional tests or monitoring to explore other potential conditions.
How often should I get this test?
The frequency of testing depends on your symptoms, medical history, and ongoing treatment. Your doctor will determine the best schedule based on your individual needs, often recommending follow-up if you have persistent or worsening symptoms.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy